DEFINITIVE NOTICE AND PROXY STATEMENT

Company

Ernexa Therapeutics Inc.

Filed

April 26, 2013

Period of Report

June 7, 2013

Accession Number

0001019687-13-001510

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →